Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935

NCT02201056 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-935
DRUG: Placebo

Sponsor

Takeda